Has Richard Rauck, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,677,368 in general payments to Richard Rauck, MD across 597 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Rauck, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Rauck, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Rauck, MD

Pain Medicine · Winston Salem, NCNPI 1205889938

Payments from drug & device makers

$1,677,368in general payments, 2019–2025

Across 597 payments — averaging $2809.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vertex$413K
Boston Scientific$327K
Collegium Pharmaceutical, Inc.$134K
Lexicon Pharmaceuticals, Inc.$108K
Pfizer$99K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$99K
plus $498K from 39 others

$23,335in research payments, 2019–2025

Across 12 payments — averaging $1944.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Purdue Pharma L.p.$14K
Saluda Medical Americas, Inc.$7K
Medtronic$2K
Eli Lilly$195

What the payments were for

Consulting fees$263,05861%
Speaking & faculty fees$129,86830%
Travel & lodging$29,8497%
Food & beverage$7,7542%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vertex	11	$413,195
Boston Scientific	191	$326,513
Collegium Pharmaceutical, Inc.	28	$134,346
Lexicon Pharmaceuticals, Inc.	22	$107,948
Pfizer	8	$98,693
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	73	$98,527
Seikagaku Corporation	18	$96,936
Regeneron	24	$84,551
Medtronic(2 entities)	46	$66,954
Saluda Medical Americas, Inc.	29	$32,529
Eli Lilly	1	$28,794
Purdue Pharma L.p.	9	$28,273
Biodelivery Sciences International, Inc.	28	$24,802
Arthrex	4	$23,356
GRT US Holding, Inc.	27	$22,265
MDD US Operations, LLC	5	$18,241
Endo Pharmaceuticals Inc.	6	$16,942
Merck	19	$15,106
Averitas Pharma Inc.	6	$9,500
Acadia Pharmaceuticals Inc	1	$6,500
Biogen	1	$6,500
Takeda Pharmaceuticals U.S.A., Inc.	1	$4,620
Pacira Therapeutics, Inc.	7	$4,141
Redhill Biopharma Inc.	2	$3,147
Scilex Pharmaceuticals Inc.	2	$1,761
SPR Therapeutics, Inc	3	$1,730
Pacira Pharmaceuticals Incorporated	1	$508
Novartis	1	$500
Abbott	3	$74
Hikma Pharmaceuticals USA	1	$64
Nevro Corp.	2	$42
Daiichi Sankyo Inc.	3	$41
MML US, Inc.	1	$33
Avanos Medical	2	$29
Nalu Medical, Inc.	1	$28
Vertiflex, Inc.	1	$27
Spinal Simplicity, LLC	1	$23
Merz Pharmaceuticals, LLC	1	$22
Baudax Bio Inc.	1	$18
Si-bone, Inc.	1	$17
Tersera Therapeutics LLC	1	$17
Forte Bio-pharma LLC	1	$16
Shionogi Inc	1	$14
Sentynl Therapeutics, Inc.	1	$14
Teva Pharmaceuticals USA, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,677,368 in reported general payments places this provider in the 95th percentile of 182 pain medicine providers in North Carolina.

See all pain medicine providers in North Carolina →

Medicare billing

Part B allowed, 2024

$50,686

Medicare patients

Services billed

551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	13	$450

Paid to pharmacies, not to this prescriber.

Other pain medicine in Winston Salem

Leonardo KapuralWinston Salem$4.1M
James NorthWinston Salem$3.7M
Christopher GilmoreWinston Salem$1.3M
Jeffrey PeacockWinston Salem$553K
Daniel BintrimWinston Salem$39K
Lauren BeaverWinston Salem$11K
Binit ShahHuntersville$863K
Courtney AumanJacksonville$210K
Javid BakshAsheville$202K
David ZubLeland$168K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →